Advice

in the absence of a submission from the holder of the marketing authorisation

follitropin delta (Rekovelle®) is not recommended for use within NHS Scotland.

Indication under review: Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies such as an in vitro fertilisation or intracytoplasmic sperm injection cycle.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Download detailed advice68KB (PDF)

Download

Medicine details

Medicine name:
follitropin delta (Rekovelle)
SMC ID:
1269/17
Indication:
controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies such as an in vitro fertilisation or intracytoplasmic sperm injection cycle.
Pharmaceutical company
Ferring Pharmaceuticals Ltd
BNF chapter
Malignant disease and immunosuppression
Submission type
Non submission
Status
Not recommended
Date advice published:
07 August 2017